China Contract Research Organization (CRO) Industry Report, 2012-2013
  • Feb/2013
  • Hard Copy
  • USD $1,850
  • Pages:65
  • Single User License
    (PDF Unprintable)       
  • USD $1,750
  • Code: ZYM040
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,700
  • Hard Copy + Single User License
  • USD $2,050
      
Compared to Europe and America, China developed pharmaceutical CRO industry 40 years later, with domestic industrial players amounting to over 500, most of which are SMEs. In general, Chinese CRO market scale occupies only 7%-10% of the world’s total, and in 2011-2012 the CRO market size of China approximated RMB22-28 billion.

Considering huge potentials of Chinese phramceutical market, intensive talent resource, relatively low cost and rich spectrum of diseases, foreign enterprises are accelerating to expand CRO market there. Presently, world-renowned CRO companies including Quintiles, Covance, PPD, CRL and ICON have set foot in China by building new establishments and M&As. In China, homegrown leaders cover WuXi AppTec Co., Ltd., Shanghai-headquartered ShangPharma Corporation, and Hangzhou Tigermed Consulting, with the respective revenue in Jan.-Sep., 2012 hitting USD374 million, USD94.47 million and USD29.84 million, the combined proportion of 14% in China CRO market.

In an aim to realize resource sharing and improve overall competitiveness, some domestic pharmaceutical CRO enterprises seek joint development by setting up alliance. A case in point is ABO, which was established in 2005 merging nine research institutes including Academy of Military Medical Sciences, National Institutes for Food and Drug Control, and National Center of Biomedical Analysis, gathering three national engineering centers and seven national engineering technology centers, with sharable hi-tech resources valuing RMB1 billion. In 2012, ABO had 38 corporate members (including Sino Biological Inc. and Pharmaron), with the total area newly increasing by 40,000 sq meters to 270,000 sq meters or more and the total revenue growing by 28.6% year-on-year to over RMB1.8 billion which accounted for 6.4% in Beijing biomedical R&D service industry. And the revenue generated by international orders rose by 14.7% YoY to RMB780 million.

In Jan. 2013, JOINN Laboratories (Beijing), a member of ABO, took over the San Francisco-based R&D and production bases of Bayer, opening a new chapter for Chinese biomedical enterprises’ acquisition of worldwide R&D bases transnational businesses in overseas countries. And JOINN Laboratories is scheduled to lavish USD100 million to set up a 300-mu(1mu=666.7sq meters)US-based Join Innovation Park, in an attempt to provide business incubator, technical support, international cooperation and other services for small-and medium-sized biomedical innovative enterprises in Silicon Valley and China.

The report highlights the followings:
20120114.gif international market, domestic macro- environment and polices, laws and regulations of China CRO industry;
20120114.gif status quo, market scale, competition pattern and development prediction of China CRO industry;
20120114.gif?Operation, CRO business and development dynamics in China of six foreign and five domestic industrial players.

1. Overview of CRO Industry
1.1 Definition & Classification
1.2 Industry Background

2. Development Environment of CRO Industry in China
2.1 International Environment
2.2 Industry Environment
2.3 Policy Environment

3. Market Analysis of CRO Industry in China
3.1 Status Quo
3.2 Market Size
3.3 Competition Pattern
3.4 Regional Market
3.4.1 Beijing
3.4.2Shanghai
3.4.3 Chengdu
3.5 Prospects

4.Key CRO Enterprises Worldwide
4.1 Covance Inc.
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Business in China
4.2 PAREXEL International
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Business in China
4.3 PPD
4.3.1 Profile
4.3.2 Operation
4.3.3 Business in China
4.4 Quintiles Transnational Corp.
4.4.1 Profile
4.4.2 Business in China
4.5 Charles River Laboratories International, Inc.
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Business in China
4.6 Asymchem Inc.
4.6.1 Profile
4.6.2 Business in China

5.Key CRO Enterprises in China
5.1 WuXi AppTec Co., Ltd.
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Development Trend and Prospects
5.2 ShangPharma Corporation
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Development Trend and Prospects
5.3 Venturepharm Laboratories Ltd.
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Development Trend and Prospects
5.4 Tigermed Consulting Co., Ltd
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 Clients and Suppliers
5.4.6 Development Trend and Prospects
5.5 Sundia MediTech Co., Ltd.
Classification of CRO
Global CRO Market Size and Growth Rate, 2007-2012
Global Key CRO Organizations and Their Business
Total Industrial Sales and Growth Rate of China’s Pharmaceutical Manufacturing, 2008-2012
Total Industrial Sales of China’s Bio-chemical Pharmaceutical Manufacturing, 2008-2012
Chinese CRO Market Size and Growth Rate, 2007-2012
Classification of Chinese CRO Companies (by Business)
Key M&A Cases of CRO Industry in China, 2007-2011
Regional Distribution of Leading Foreign CROs in China
Revenue and YoY Growth Rate of ABO, 2010-2012
Sponsors of CRO in Zhonguancun (Listed in No Particular Order)
Platform Edge of Shanghai Pharma Engine
Major CRO Enterprises of Shanghai Pharma Engine
Revenue and Operating Profit of Covance, 2009-2012
Revenue of Covance by Business, 2010-2012
Revenue and Operating Profit of PAREXEL, 2009-2012
Revenue of PAREXEL by Business, 2009-2012
Revenue of PAREXEL by Region Worldwide, 2009-2012
Revenue of PPD, 2007-2010
Corporate Advantages of Excel PharmaStudies, Inc.
Revenue and Operating Profit of CRL, 2009-2012
Revenue Breakdown of CRL by Business, 2009-2012
Asymchem Inc’s Companies and Main Businesses in China
Operation of Asymchem Inc.(Tianjin), 2008 & Jan.2009-May, 2009
Branch Distribution of WuXi AppTec Co., Ltd
Revenue and Gross Margin of WuXi AppTec Co., Ltd, 2008-2012
Main Businesses of WuXi AppTec Co., Ltd
Revenue of WuXi AppTec Co., Ltd by Business, 2010-2012
Big Events of WuXi AppTec Co., Ltd, 2011-2012
Revenue and Gross Margin of WuXi AppTec Co., Ltd, 2011-2015E
Distribution of Subsidiaries of ShangPharma Corporation
Four R&D Bases of ShangPharma Corporation
Revenue and Gross Profit of ShangPharma Corporation, 2008-2012
Revenue Breakdown of ShangPharma Corporation by Business, 2009-2011
Shareholding (Joint-stock) Companies of Venturepharm Laboratories Ltd
Revenue and Gross Profit of Venturepharm Laboratories Ltd, 2007-2011
Revenue of Venturepharm Laboratories Ltd by Business, 2010-2011
Number of Cases of Venturepharm laboratories Approved by SFDA, 2002-2011
Seven Subsidiaries and Business Distribution of Tigermed Consulting Co., Ltd
Domestic and Foregin Customer Distribution of Tigermed by Region
Revenue and Profit of Tigermed, 2009-2012
New Contract Value and Average Contract Value of New Contracts of Tigermed, 2009-2011
New Contract Number and Value of Tigermed by Business, 2009-2011
Operating Revenue and Operating Cost of Tigermed by Business, 2009-2011
Revenue Breakdown of Tigermed by Region, 2009-2011
Revenue and Proportion from Clinical Test Technical Service Business of Tigermed, 2009-2011 
Consolidated Gross Margin of Tigermed, 2009-2011
Gross Margin of Tigermed by Business, 2009-2011
Name List and Revenue Contribution of Tigermed’s Top 5 Clients, 2009-2011
Name list and Procurement of Tigermed’s Top 5 Suppliers,2009-2011
Number of Clinical Research Projects of Tigermed by Business  
Clinical Research Projects of Tigermed by Disease 
IPO Investment Projects of Tigermed 
Business Layout of Tigermed after Production of Fundraising Projects

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统